Suloctidil: a novel inhibitor of platelet aggregation in human beings.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000328:Adult; D001241:Aspirin / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D003094:Collagen / Q000037:antagonists & inhibitors; D004176:Dipyridamole / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D013997:Time Factors
D005343:Fibrinolytic Agents; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D003094:Collagen; D001241:Aspirin; D004837:Epinephrine